A screen for apoptotic synergism between clinical relevant nephrotoxicant and the cytokine TNF-α

Toxicology in Vitro

Volumn 27, Issue 8, 2013, Pages 2264-2272

  Benedetti, Giulia ^a   Ramaiahgaris, Sreenivasa ^a   Herpers, Bram ^a   Van De Water, Bob ^a   Price, Leo S ^a   De Graauw, Marjo ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

Author keywords

In vitro cytotoxicity assay; Mouse immortalized proximal tubular epithelial cells; Nephrotoxicity; Synergistic apoptosis; TNF

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ADEFOVIR; CARMUSTINE; CEFALORIDINE; CEFALOTIN; CISPLATIN; CYCLOSPORIN A; DICLOFENAC; FOSCARNET; GENTAMICIN; METHOTREXATE; MITOMYCIN; NEOMYCIN; PARACETAMOL; PHENACETIN; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA; VALACICLOVIR; ZIDOVUDINE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOMETRY; EPITHELIUM CELL; FLUORESCENCE ANALYSIS; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NEPHRITIS; NEPHROTOXICITY; NONHUMAN;

IN VITRO CYTOTOXICITY ASSAY; MOUSE IMMORTALIZED PROXIMAL TUBULAR EPITHELIAL CELLS; NEPHROTOXICITY; SYNERGISTIC APOPTOSIS; TNF-Α;

ANIMALS; APOPTOSIS; BIOLOGICAL ASSAY; CELLS, CULTURED; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; EPITHELIAL CELLS; KIDNEY TUBULES, PROXIMAL; MICE; NECROSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84885996960     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2013.09.004     Document Type: Article

References (64)

1. Akcay A., Nguyen Q., Edelstein C.L. Mediators of inflammation in acute kidney injury. Mediators of Inflammation 2009, 2009:137072.
2. Araujo L.P., Truzzi R.R., Mendes G.E., Luz M.A., Burdmann E.A., Oliani S.M. Interaction of the anti-inflammatory annexin A1 protein and tacrolimus immunosuppressant in the renal function of rats. American Journal of Nephrology 2010, 31:527-533.
3. Araujo L.P., Truzzi R.R., Mendes G.E., Luz M.A., Burdmann E.A., Oliani S.M. Annexin A1 protein attenuates cyclosporine-induced renal hemodynamics changes and macrophage infiltration in rats. Inflammation Research 2012, 61:189-196.
4. Asvadi I., Hajipour B., Asvadi A., Asl N.A., Roshangar L., Khodadadi A. Protective effect of pentoxyfilline in renal toxicity after methotrexate administration. European Review for Medical and Pharmacological Sciences 2011, 15:1003-1009.
5. Benedetti G., Fredriksson L., Herpers B., Meerman J., van de Water B., de Graauw M. TNF-α-mediated NF-κB survival signaling impairment by cisplatin enhances JNK activation allowing synergistic apoptosis of renal proximal tubular cells. Biochemical pharmacology 2012.
6. Boulares A.H., Giardina C., Inan M.S., Khairallah E.A., Cohen S.D. Acetaminophen inhibits NF-kappaB activation by interfering with the oxidant signal in murine Hepa 1-6 cells. Toxicological Sciences: An Official Journal of the Society of Toxicology 2000, 55:370-375.
7. Bush K.T., Keller S.H., Nigam S.K. Genesis and reversal of the ischemic phenotype in epithelial cells. The Journal of Clinical Investigation 2000, 106:621-626.
8. Chou T.C. Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Research 2010, 70:440-446.
9. Cicora F., Roberti J., Lausada N., Gonzalez P., Guerrieri D., Stringa P., Raimondi C. Immunosuppression in kidney donors with rapamycin and tacrolimus. Proinflammatory cytokine expression. Medicina 2012, 72:3-9.
10. Cordes N. Integrin-mediated cell-matrix interactions for prosurvival and antiapoptotic signaling after genotoxic injury. Cancer Letters 2006, 242:11-19.
11. Cuevas P., Diaz-Gonzalez D., Dujovny M. Glioma cell-associated sustained activation of the transcription factor, nuclear factor-kappa B, was inhibited by neomycin. Neurological Research 2003, 25:271-274.
12. De Simone C., Tzantzoglou S., Santini G., Vullo V., di Orio F., Leuter C., Jirillo E., Delia S. Clinical and immunologic effects of combination therapy with intravenous immunoglobulins and AZT in HIV-infected patients. Immunopharmacology and Immunotoxicology 1991, 13:447-458.
13. Du S., Hiramatsu N., Hayakawa K., Kasai A., Okamura M., Huang T., Yao J., Takeda M., Araki I., Sawada N., Paton A.W., Paton J.C., Kitamura M. Suppression of NF-kappaB by cyclosporin a and tacrolimus (FK506) via induction of the C/EBP family: implication for unfolded protein response. Journal of Immunology 2009, 182:7201-7211.
14. Duff T., Carter S., Feldman G., McEwan G., Pfaller W., Rhodes P., Ryan M., Hawksworth G. Transepithelial resistance and inulin permeability as endpoints in in vitro nephrotoxicity testing. Alternatives to Laboratory Animals: ATLA 2002, 30(2):53-59.
15. Garcia-Trapero J., Carceller F., Dujovny M., Cuevas P. Perivascular delivery of neomycin inhibits the activation of NF-kappaB and MAPK pathways, and prevents neointimal hyperplasia and stenosis after arterial injury. Neurological Research 2004, 26:816-824.
16. Geleilete T.J., Melo G.C., Costa R.S., Volpini R.A., Soares T.J., Coimbra T.M. Role of myofibroblasts, macrophages, transforming growth factor-beta endothelin, angiotensin-II, and fibronectin in the progression of tubulointerstitial nephritis induced by gentamicin. Journal of Nephrology 2002, 15:633-642.
17. Ghosh J., Das J., Manna P., Sil P.C. Acetaminophen induced renal injury via oxidative stress and TNF-alpha production: therapeutic potential of arjunolic acid. Toxicology 2010, 268:8-18.
18. Helal G.K., Aleisa A.M., Helal O.K., Al-Rejaie S.S., Al-Yahya A.A., Al-Majed A.A., Al-Shabanah O.A. Metallothionein induction reduces caspase-3 activity and TNFalpha levels with preservation of cognitive function and intact hippocampal neurons in carmustine-treated rats. Oxidative Medicine and Cellular Longevity 2009, 2:26-35.
19. Ho E.S., Lin D.C., Mendel D.B., Cihlar T. Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1. Journal of the American Society of Nephrology: JASN 2000, 11:383-393.
20. Hu J.J., Lee M.J., Vapiwala M., Reuhl K., Thomas P.E., Yang C.S. Sex-related differences in mouse renal metabolism and toxicity of acetaminophen. Toxicology and Applied Pharmacology 1993, 122:16-26.
21. Jang K.J., Mehr A.P., Hamilton G.A., McPartlin L.A., Chung S., Suh K.Y., Ingber D.E. Human kidney proximal tubule-on-a-chip for drug transport and nephrotoxicity assessment. Integrative Biology Quantitative: Biosciences from Nano to Macro 2013.
22. Jeon S.H., Park H.M., Kim S.J., Lee M.Y., Kim G.B., Rahman M.M., Woo J.N., Kim I.S., Kim J.S., Kang H.S. Taurine reduces FK506-induced generation of ROS and activation of JNK and Bax in Madin Darby canine kidney cells. Human & Experimental Toxicology 2010, 29:627-633.
23. Juan S.H., Chen C.H., Hsu Y.H., Hou C.C., Chen T.H., Lin H., Chu Y.L., Sue Y.M. Tetramethylpyrazine protects rat renal tubular cell apoptosis induced by gentamicin. Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 2007, 22:732-739.
24. Kays S.E., Schnellmann R.G. Regeneration of renal proximal tubule cells in primary culture following toxicant injury: response to growth factors. Toxicology and Applied Pharmacology 1995, 132:273-280.
25. Kurokawa M., Ghosh S.K., Ramos J.C., Mian A.M., Toomey N.L., Cabral L., Whitby D., Barber G.N., Dittmer D.P., Harrington W.J. Azidothymidine inhibits NF-kappaB and induces Epstein-Barr virus gene expression in Burkitt lymphoma. Blood 2005, 106:235-240.
26. Lauzurica R., Pastor M.C., Bayes B., Malumbres S., Homs M., Llopis M.A., Bonet J., Romero R. Subclinical inflammation in renal transplant recipients: impact of cyclosporine microemulsion versus tacrolimus. Transplantation Proceedings 2007, 39:2170-2172.
27. Li W., Choy D.F., Lam M.S., Morgan T., Sullivan M.E., Post J.M. Use of cultured cells of kidney origin to assess specific cytotoxic effects of nephrotoxins. Toxicology in vitro: An International Journal Published in Association with BIBRA 2003, 17:107-113.
28. Li W., Lam M., Choy D., Birkeland A., Sullivan M.E., Post J.M. Human primary renal cells as a model for toxicity assessment of chemo-therapeutic drugs. Toxicology In vitro: An International Journal Published in Association with BIBRA 2006, 20:669-676.
29. Limonciel A., Aschauer L., Wilmes A., Prajczer S., Leonard M.O., Pfaller W., Jennings P. Lactate is an ideal non-invasive marker for evaluating temporal alterations in cell stress and toxicity in repeat dose testing regimes. Toxicology In vitro: An International Journal Published in Association with BIBRA 2011, 25:1855-1862.
30. Liu M., Chien C.C., Burne-Taney M., Molls R.R., Racusen L.C., Colvin R.B., Rabb H. A pathophysiologic role for T lymphocytes in murine acute cisplatin nephrotoxicity. Journal of the American Society of Nephrology: JASN 2006, 17:765-774.
31. Lo S.Z., Steer J.H., Joyce D.A. Tumor necrosis factor-alpha promotes survival in methotrexate-exposed macrophages by an NF-kappaB-dependent pathway. Arthritis Research & Therapy 2011, 13:R24.
32. Martins L., Ventura A., Branco A., Carvalho M.J., Henriques A.C., Dias L., Sarmento A.M., Amil M. Cyclosporine versus tacrolimus in kidney transplantation: are there differences in nephrotoxicity?. Transplantation Proceedings 2004, 36:877-879.
33. Morlat P., Chene G., Ragnaud J.M., Mercie P., Grobost F., Bernard N., Lacoste D., Beylot J., Aubertin J. Evolution of tumor necrosis factor-alpha serum concentrations in HIV infected individuals treated with zidovudine. Pathologie-Biologie 1996, 44:716-719.
34. Naughton C.A. Drug-induced nephrotoxicity. American Family Physician 2008, 78:743-750.
35. Nguyen D.T., Eskandai M.K., DeForge L.E., Raiford C.L., Strieter R.M., Kunkel S.L., Remick D.G. Cyclosporin a modulation of tumor necrosis factor gene expression and effects in vitro and in vivo. Journal of Immunology 1990, 144:3822-3828.
36. Pabla N., Dong Z. Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney International 2008, 73:994-1007.
37. Pallet N., Thervet E., Anglicheau D. C-Jun-N-terminal kinase signaling is involved in cyclosporine-induced epithelial phenotypic changes. Journal of Transplantation 2012, 2012:348604.
38. Peces R., Urra J.M. Effect of calcium-channel blocker on tumour necrosis factor alpha (TNF alpha) production in cyclosporin-treated renal transplant recipients. Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 1995, 10:871-873.
39. Pfaller W., Gstraunthaler G. Nephrotoxicity testing in vitro - what we know and what we need to know. Environmental Health Perspectives 1998, 106(Suppl 2):559-569.
40. Piao R.L., Liu Y.Y., Tian D., Ma Z.H., Zhang M., Zhao C., Niu J.Q. Adefovir dipivoxil modulates cytokine expression in Th1/Th2 cells in patients with chronic hepatitis B. Molecular Medicine Reports 2012, 5:184-189.
41. Pichler R.H., Franceschini N., Young B.A., Hugo C., Andoh T.F., Burdmann E.A., Shankland S.J., Alpers C.E., Bennett W.M., Couser W.G., et al. Pathogenesis of cyclosporine nephropathy: roles of angiotensin II and osteopontin. Journal of the American Society of Nephrology: JASN 1995, 6:1186-1196.
42. Pogrebniak H.W., Matthews W., Pass H.I. Chemotherapy amplifies production of tumor necrosis factor. Surgery 1991, 110:231-237.
43. Puigvert, J.C., de Bont, H., van de Water, B., Danen, E.H., 2010. High-throughput live cell imaging of apoptosis. Curr Protoc Cell Biol 18(18). pp. 10, 11-13.
44. Quiros Y., Vicente-Vicente L., Morales A.I., Lopez-Novoa J.M., Lopez-Hernandez F.J. An integrative overview on the mechanisms underlying the renal tubular cytotoxicity of gentamicin. Toxicological Sciences 2011, 119:245-256.
45. Ramesh G., Brian Reeves W. Cisplatin increases TNF-alpha mRNA stability in kidney proximal tubule cells. Renal Failure 2006, 28:583-592.
46. Ramesh G., Reeves W.B. TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. The Journal of Clinical Investigation 2002, 110:835-842.
47. Ramesh G., Reeves W.B. TNFR2-mediated apoptosis and necrosis in cisplatin-induced acute renal failure. American Journal of Physiology. Renal Physiology 2003, 285:F610-F618.
48. Ramesh G., Kimball S.R., Jefferson L.S., Reeves W.B. Endotoxin and cisplatin synergistically stimulate TNF-alpha production by renal epithelial cells. American Journal of Physiology. Renal Physiology 2007, 292:F812-F819.
49. Remick D.G., Nguyen D.T., Eskandari M.K., Strieter R.M., Kunkel S.L. Cyclosporine A inhibits TNF production without decreasing TNF mRNA levels. Biochemical and Biophysical Research Communications 1989, 161:551-555.
50. Schwertz D.W., Kreisberg J.I., Venkatachalam M.A. Gentamicin-induced alterations in pig kidney epithelial (LLC-PK1) cells in culture. The Journal of Pharmacology and Experimental Therapeutics 1986, 236:254-262.
51. Stokman G., Qin Y., Genieser H.G., Schwede F., de Heer E., Bos J.L., Bajema I.M., van de Water B., Price L.S. Epac-Rap signaling reduces cellular stress and ischemia-induced kidney failure. Journal of the American Society of Nephrology: JASN 2011, 22:859-872.
52. Tune B.M. Nephrotoxicity of beta-lactam antibiotics: mechanisms and strategies for prevention. Pediatric Nephrology 1997, 11:768-772.
53. Uwai Y., Ida H., Tsuji Y., Katsura T., Inui K. Renal transport of adefovir, cidofovir, and tenofovir by SLC22A family members (hOAT1, hOAT3, and hOCT2). Pharmaceutical Research 2007, 24:811-815.
54. van Erk M.J., Wopereis S., Rubingh C., van Vliet T., Verheij E., Cnubben N.H., Pedersen T.L., Newman J.W., Smilde A.K., van der Greef J., Hendriks H.F., van Ommen B. Insight in modulation of inflammation in response to diclofenac intervention: a human intervention study. BMC Medical Genomics 2010, 3:5.
55. Volpini R.A., Costa R.S., da Silva C.G., Coimbra T.M. Inhibition of nuclear factor-kappaB activation attenuates tubulointerstitial nephritis induced by gentamicin. Nephron. Physiology 2004, 98:97-106.
56. Weber F., Freudinger R., Schwerdt G., Gekle M. A rapid screening method to test apoptotic synergisms of ochratoxin A with other nephrotoxic substances. Toxicology In vitro: An International Journal Published in Association with BIBRA 2005, 19:135-143.
57. Weimer R., Melk A., Daniel V., Friemann S., Padberg W., Opelz G. Switch from cyclosporine A to tacrolimus in renal transplant recipients: impact on Th1, Th2, and monokine responses. Human Immunology 2000, 61:884-897.
58. Wieser M., Stadler G., Jennings P., Streubel B., Pfaller W., Ambros P., Riedl C., Katinger H., Grillari J., Grillari-Voglauer R. HTERT alone immortalizes epithelial cells of renal proximal tubules without changing their functional characteristics. American Journal of Physiology. Renal Physiology 2008, 295:F1365-F1375.
59. Williams P.D., Bennett D.B., Gleason C.R., Hottendorf G.H. Correlation between renal membrane binding and nephrotoxicity of aminoglycosides. Antimicrobial Agents and Chemotherapy 1987, 31:570-574.
60. Wu Y., Connors D., Barber L., Jayachandra S., Hanumegowda U.M., Adams S.P. Multiplexed assay panel of cytotoxicity in HK-2 cells for detection of renal proximal tubule injury potential of compounds. Toxicology In vitro: An International Journal Published in Association with BIBRA 2009, 23:1170-1178.
61. Yalavarthy R., Edelstein C.L. Therapeutic and predictive targets of AKI. Clinical Nephrology 2008, 70:453-463.
62. Yard B.A., Pancham R.R., Paape M.E., Daha M.R., van Es L.A., van der Woude F.J. CsA, FK506, corticosteroids and rapamycin inhibit TNF alpha production by cultured PTEC. Kidney International 1993, 44:352-358.
63. Zager R.A., Johnson A.C., Geballe A. Gentamicin suppresses endotoxin-driven TNF-alpha production in human and mouse proximal tubule cells. American Journal of Physiology. Renal Physiology 2007, 293:F1373-F1380.
64. Zhang L., Mu X., Fu J., Zhou Z. In vitro cytotoxicity assay with selected chemicals using human cells to predict target-organ toxicity of liver and kidney. Toxicology In vitro: An International Journal Published in Association with BIBRA 2007, 21:734-740.